These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16419319)

  • 1. Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). The New York City patient: a case of progression, pathogenesis, and public health.
    Blankson J
    Hopkins HIV Rep; 2005 Mar; 17(2):10-1. PubMed ID: 16419319
    [No Abstract]   [Full Text] [Related]  

  • 2. Report from Boston: the 10th Conference on Retroviruses and Opportunistic Infections (CROI).
    Gallant JE
    Hopkins HIV Rep; 2003 Mar; 15(2):1-2, 11. PubMed ID: 12739498
    [No Abstract]   [Full Text] [Related]  

  • 3. 12th Retrovirus Conference. Super bug or super dud? CROI forum provides particulars of the New York case.
    Berry J
    Posit Aware; 2005; 16(3):26-7. PubMed ID: 16477706
    [No Abstract]   [Full Text] [Related]  

  • 4. The more things change..
    Zuniga JM
    IAPAC Mon; 2005 Mar; 11(3):60-1. PubMed ID: 16110533
    [No Abstract]   [Full Text] [Related]  

  • 5. Can drugs catch up with HIV? 12th Conference on Retroviruses and Opportunistic Infections. February 22-25, 2005, Boston.
    Mascolini M
    IAPAC Mon; 2005 Mar; 11(3):68-85. PubMed ID: 16110535
    [No Abstract]   [Full Text] [Related]  

  • 6. Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). Reduced bone mineral density in HIV-infected patients.
    Brown TT
    Hopkins HIV Rep; 2005 May; 17(3):12-4, 16. PubMed ID: 16419313
    [No Abstract]   [Full Text] [Related]  

  • 7. New resistant strain of HIV worries health officials.
    AIDS Policy Law; 2005 Feb; 20(4):5. PubMed ID: 15779101
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reactions to the New York "supervirus". A challenge in primary resistance].
    Paukstadt W
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():86. PubMed ID: 16385890
    [No Abstract]   [Full Text] [Related]  

  • 9. [New knowledge and new challenges: 4th National Conference on Retroviruses & Opportunistic Infections].
    Agosto M; Ehara R
    Sidahora; 1997; ():18-21. PubMed ID: 11364490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). Complications/toxicity of HIV therapy.
    Moore RD; Confrancesco J
    Hopkins HIV Rep; 2005 May; 17(3):1-5, 9. PubMed ID: 16419310
    [No Abstract]   [Full Text] [Related]  

  • 11. Special coverage: Retroviruses Conference 2006. Treatment interruption continues to be controversial strategy in HIV care. CROI studies show mixed results.
    AIDS Alert; 2006 Mar; 21(3):13-6. PubMed ID: 17378059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). The treatment of experienced patients and resistance mechanisms.
    Lucas GM
    Hopkins HIV Rep; 2004 Mar; 16(2):6-7, 15. PubMed ID: 15119309
    [No Abstract]   [Full Text] [Related]  

  • 13. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). CD4 lymphocyte depletion: where have all the cells gone?
    Kim S; Blankson JN
    Hopkins HIV Rep; 2007 Mar; 19(2):10-2. PubMed ID: 17882788
    [No Abstract]   [Full Text] [Related]  

  • 14. Report from the 12th Retrovirus Conference. Acute and recent HIV infection.
    Hicks CB
    AIDS Clin Care; 2005 Apr; 17(4):33-4. PubMed ID: 15875306
    [No Abstract]   [Full Text] [Related]  

  • 15. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). The tenacity of NNRTI drug resistance.
    Persaud D; Gallant JE
    Hopkins HIV Rep; 2004 Mar; 16(2):1, 5, 15. PubMed ID: 15119307
    [No Abstract]   [Full Text] [Related]  

  • 16. 12th Conference on Retroviruses and Opportunistic Infections (CROI).
    HIV Clin Trials; 2005; 6(3):169-81. PubMed ID: 16192250
    [No Abstract]   [Full Text] [Related]  

  • 17. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). Management of treatment-naïve patients.
    Gallant JE
    Hopkins HIV Rep; 2007 Mar; 19(2):1-3, 12. PubMed ID: 17882785
    [No Abstract]   [Full Text] [Related]  

  • 18. When to start HAART: still a controversy. Report from Seattle: the 9th Conference on Retroviruses and Opportunistic Infections (CROI).
    Sterling TR
    Hopkins HIV Rep; 2002 Mar; 14(2):1-3. PubMed ID: 12030208
    [No Abstract]   [Full Text] [Related]  

  • 19. Report from the 13th Conference on Retroviruses and Opportunistic Infections (CROI), February 5-8, 2006, Denver, Colorado.
    TreatmentUpdate; 2006; 18(2):4-6. PubMed ID: 17230629
    [No Abstract]   [Full Text] [Related]  

  • 20. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). New data on treatment-experienced patients and drug resistance.
    Lucas GM
    Hopkins HIV Rep; 2007 Mar; 19(2):4-6. PubMed ID: 17882786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.